Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$81,127
+$81 QoQ
Shares Held
105
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $3,859,296 across 14 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
|
168,750 | $1,604,812 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
56,723 | $847,441 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,127 | $559,814 | |
| 4 | ANAB |
Anaptysbio, Inc
|
5,000 | $337,500 | |
| 5 | GLSI |
Greenwich LifeSciences, Inc.
|
10,740 | $251,960 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,215 | $175,627 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
2,500 | $44,925 | |
| 8 | INSM |
INSMED Inc
|
200 | $21,324 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $81,127 | 105 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,046 | 105 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,736 | 60 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,500 | 60 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $38,688 | 61 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $49,863 | 70 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $163,993 | 156 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $162,909 | 155 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $149,185 | 155 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $136,134 | 155 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $158,008 | 192 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $147,300 | 205 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $161,868 | 197 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $111,831 | 157 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $106,774 | 155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $91,625 | 155 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $109,651 | 157 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $109,884 | 174 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $95,013 | 157 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $94,393 | 169 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $124,908 | 264 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $127,541 | 264 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $147,781 | 264 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $155,912 | 250 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $117,189 | 240 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||